Mortality of patients with childhood onset (0-17 years) Type I diabetes in Israel: a population-based study

T Laron-Kenet1, I Shamis, S Weitzman

  • 1Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center, Tel Aviv University, Israel.

Diabetologia
|November 29, 2001
PubMed

Insights

Children with Type I diabetes face significantly higher mortality rates. This study confirms increased mortality risk for childhood-onset diabetes compared to the general population.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Epidemiology

Background:

  • Type I diabetes, also known as insulin-dependent diabetes, is a chronic condition.
  • Childhood-onset diabetes requires lifelong management and monitoring.

Purpose of the Study:

  • To investigate the mortality rate in individuals diagnosed with Type I diabetes during childhood in Israel.
  • To compare the mortality risk of this cohort with the general population.

Main Methods:

  • A nationwide cohort of 1,861 children and adolescents (0-17 years) diagnosed with Type I diabetes between 1965 and 1993 in Israel was analyzed.
  • Mortality data were tracked up to October 1996 with 100% ascertainment.

Main Results:

  • A total of 37 deaths occurred, revealing a significant excess mortality (p < 0.001) with a standard mortality ratio three times higher than the general population.
  • Leading causes of death included chronic diabetes complications (n=9), ketoacidosis (n=8), and infections (n=8).
  • Higher prevalence of nephropathy, neuropathy, and anemia was observed in females among those who died. 17 deceased patients had central nervous system diseases.

Conclusions:

  • Childhood-onset Type I diabetes is associated with a substantially increased risk of mortality.
  • These findings underscore the importance of comprehensive management and ongoing research for pediatric diabetes populations.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...